Global Ulcerative Colitis Market 2016-2020
Published: May 2016 | Pages: 67 | SKU: IRTNTR8159 |
Global ulcerative colitis industry forecast
According to the ulcerative colitis market analysis, Technavio’s research analysts predict that this market will grow steadily at a CAGR of approximately 7% during the forecast period. The increase in patient assistance programs is a major driver of the market. The provision of these programs by vendors will increase the preference for branded drugs because the out-of-pocket charges would be less as the drugs are obtained at lower costs. The increase in the prevalence of ulcerative colitis is another factor, which is expected to boost ulcerative colitis market growth during the forecast period. According to CDC, the worldwide incidence of ulcerative colitis is between 0.5 to 24.5 cases per 100,000 persons per year. The recurrence of the disease’s symptoms is also high. According to Crohn's and colitis foundation of America, about 30% of the people on remission are expected to suffer from the disease flare-up in the future following the treatment and remission.
Segmentation by molecule type and analysis of the ulcerative colitis market
- Biologics
- Small molecules
In terms of molecule type, the biologics segment dominated the ulcerative colitis market in 2015. The better efficacy and safety of these drugs along with increased uptake, especially in developed markets such as the US and Europe, fuel the growth of this segment.
Geographical segmentation and analysis of the ulcerative colitis market
- Americas
- APAC
- EMEA
The Americas accounted for approximately 60% of the market share during 2015 and is expected to grow at a CAGR of around 5% during the forecast period. The increased uptake of biologics, a growing number of ulcerative colitis patients, and the associated health issues are the primary drivers of market growth in this region.
Competitive landscape and key vendors
The global ulcerative colitis market offers a vast opportunity for vendors due to the absence of effective treatment options for ulcerative colitis. As a result, both big and small vendors are shifting their focus and making huge investments in R&D to usher inadequate treatments for ulcerative colitis. Thus, the competition in the market has increased tremendously and to endure this tough competition, vendors need to develop improved and superior techniques to stay on top.
The leading vendors in the market are
- AbbVie
- Janssen Pharmaceutical
- Merck
- Takeda Pharmaceuticals
Other prominent vendors in the market include Abbott, Ajinomoto Pharmaceuticals, Altheus Therapeutics, Amgen, Arena Pharmaceuticals, Astellas Pharma, AstraZeneca, Avaxia Biologics, BioLineRx, Celgene, Cosmo Pharmaceuticals, Eisai, Ferring Pharmaceuticals, Galapagos NV, Genentech, Gilead Sciences, GlaxoSmithKline, Hutchison MediPharma, Immune Pharmaceuticals, InDex Pharmaceuticals, Kaken Pharmaceutical, Kissei Pharmaceutical, Kyowa Hakko Kirin, Lipid Therapeutics, Meda, Mitsubishi Tanabe, Mochida Pharmaceutical, Morphotek, Nestle, Pfizer, Procter & Gamble, Qu Biologics, Receptos, Salix Pharmaceuticals, Santarus, Shield Therapeutics, Shire Pharmaceuticals, Sterna Biologicals, Tillotts Pharma, TopiVert, UCB, and Zeria.
Key questions answered in the report include:
- What will the market size and growth rate be in 2020?
- What are the key factors driving the global ulcerative colitis market?
- What are the key market trends impacting the growth of the global ulcerative colitis market?
- What are the challenges to market growth?
- Who are the key vendors in the global ulcerative colitis market?
- What are the market opportunities and threats faced by the vendors in the global ulcerative colitis market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global ulcerative colitis market?
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Table of contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Disease overview
- Understanding the disease
- Etiology
- Epidemiology
- Symptoms
- Diagnosis and testing
- Treatment
- Prognosis
- Economic burden
- Reimbursement scenario
PART 06: Pipeline analysis
- Z-206
- MD-0901
- TP05
- Stelara
- Etrolizumab
- Xeljanz
- HMPL-004
- Kappaproct
- AJG511
- AJM300
PART 07: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 08: Market segmentation by molecule type
- Biologics
- Small molecules
- Biologics segment in ulcerative colitis drugs market
- Small molecules segment in ulcerative colitis drugs market
PART 09: Market segmentation by dosage form
- Solid
- Liquid
PART 10: Market segmentation by route of administration
- Oral
- Parenteral
PART 11: Geographical segmentation
- Global ulcerative colitis drugs market by geography 2015-2020
- Ulcerative colitis drugs market in Americas
- Ulcerative colitis drugs market in EMEA
- Ulcerative colitis drugs market in APAC
PART 12: Market drivers
- Increase in patient assistance programs
- High unmet needs
- Tentative approval of candidates in pipeline
PART 13: Impact of drivers
PART 14: Market challenges
- High cost of drugs
- Patent expiries
- Adverse effects of drugs
- Unknown disease etiology
PART 15: Impact of drivers and challenges
PART 16: Market trends
- Growing public awareness
- Rising use of biologics
- Emergence of biosimilars
- Strategic alliances
PART 17: Vendor landscape
- Competitive scenario
- Market share analysis 2015
- AbbVie
- Janssen Biotech
- Merck
- Takeda Pharmaceuticals
- Other prominent vendors
PART 18: Appendix
- List of abbreviations
PART 19: Explore Technavio
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis